• 
  Véronique Vendrely, Philippe Ronchin, Mathieu Minsat, Karine Le Malicot, Claire Lemanski, et al.. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial. Radiotherapy & Oncology, 2023, 186, pp.109742. ⟨10.1016/j.radonc.2023.109742⟩. ⟨hal-04163679⟩
• 
  D. Dano, A. Lardy-Cleaud, A. Monneur, N. Quenel-Tueux, C. Levy, et al.. Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME). ESMO Open, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩. ⟨hal-03426433⟩
• 
  F. Lemaire, R. Millon, J. Young, A. Cromer, Christine Wasylyk, et al.. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). British Journal of Cancer, 2003, 89 (10), pp.1940-1949. ⟨10.1038/sj.bjc.6601373⟩. ⟨hal-04143693⟩
• 
  Jérôme Fayette, Joël Guigay, Christophe Le Tourneau, Marian Degardin, Frédéric Peyrade, et al.. Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: Phase II UNICANCER trial ORL03. Oncotarget, 2017, 8 (31), pp.51830-51839. ⟨10.18632/oncotarget.15901⟩. ⟨hal-02558669⟩
• 
  Cédric Hemon, Bastien Rigaud, Anais Barateau, Florian Tilquin, Vincent Noblet, et al.. Contour-guided deep learning based deformable image registration for dose monitoring during CBCT-guided radiotherapy of prostate cancer. Journal of Applied Clinical Medical Physics, 2023, pp.e13991. ⟨10.1002/acm2.13991⟩. ⟨hal-04112657⟩
• 
  Francois-Xavier Danlos, Matthieu Texier, Bastien Job, Severine Mouraud, Lydie Cassard, et al.. Genomic Instability and Pro-Tumoral Inflammation are associated with Primary Resistance to Anti-PD1 + Anti-Angiogenesis in Malignant Pleural Mesothelioma. Cancer Discovery, 2023, pp.OF1-OF22. ⟨10.1158/2159-8290.CD-22-0886⟩. ⟨hal-03972355⟩
• 
  Jean-Frédéric Blanc, Faiza Khemissa, Jean-Pierre Bronowicki, Carole Monterymard, Jean-Marc Perarnau, et al.. Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis. Hepatology international, 2021, 15 (1), pp.93-104. ⟨10.1007/s12072-020-10120-3⟩. ⟨hal-03881843⟩
• 
  C. Xhaard, A. Dumas, V. Souchard, Y. Ren, F. Borson-Chazot, et al.. Are dietary reports in a case-control study on thyroid cancer biased by risk perception of Chernobyl fallout?. Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2017, 65 (4), pp.301-308. ⟨10.1016/j.respe.2017.02.002⟩. ⟨hal-04043710⟩
• 
  Thomas Raze, Brigitte Lacour, Anne Cowppli-Bony, Patricia Delafosse, Michel Velten, et al.. Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved Survival. Journal of Adolescent and Young Adult Oncology, 2021, 10 (1), pp.29-45. ⟨10.1089/jayao.2020.0017⟩. ⟨hal-04020187⟩
• 
  Marie Auvray Kuentz, Vincent Hautefeuille, Louis de Mestier, Clelia Coutzac, Thierry Lecomte, et al.. Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. International Journal of Cancer, 2023, ⟨10.1002/ijc.34414⟩. ⟨hal-03969427⟩
• 
  Elyette Broly, Philippe Barthélémy, Saïd Ciftci, Christian Borel, Martin Broly, et al.. Hidden intra-mandibular carcinoma cuniculatum appearing in a patient with metastatic prostate cancer: a case report. BMC Oral Health, 2019, 19 (1), pp.54. ⟨10.1186/s12903-019-0745-1⟩. ⟨hal-03889807⟩
• 
  Christian Borel, Olivier Regnier-Gavier, Hélène Carinato, Sébastien Guihard, Delphine Antoni, et al.. Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer. Oncotarget, 2018, 9 (101), pp.37581-37588. ⟨10.18632/oncotarget.26506⟩. ⟨hal-03881981⟩
• 
  Clélia Coutzac, Frédéric Bibeau, Méher Ben Abdelghani, Thomas Aparicio, Romain Cohen, et al.. Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial. Digestive and Liver Disease, 2022, 54 (10), pp.1335-1341. ⟨10.1016/j.dld.2022.07.008⟩. ⟨hal-03837196⟩
• 
  Alexandre Detappe, Clélia Mathieu, Caining Jin, Michael P. Agius, Marie-Charlotte Deringer, et al.. Anti-MUC1-C Antibody–Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 2020, 108 (5), pp.1380-1389. ⟨10.1016/j.ijrobp.2020.06.069⟩. ⟨hal-03093629⟩
• 
  Waisse Waissi, Anaïs Nicol, Matthieu Jung, Marc Rousseau, Delphine Jarnet, et al.. Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation. Cancers, 2021, 13 (3), pp.527. ⟨10.3390/cancers13030527⟩. ⟨hal-03160783⟩
• 
  Paul Cottu, Bruno Coudert, David Perol, Anne Doly, Julien Manson, et al.. Evolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2–targeted treatments: Results from the french personalized reimbursement model database (2011–2018). European Journal of Cancer, 2020, 141, pp.209 - 217. ⟨10.1016/j.ejca.2020.10.012⟩. ⟨hal-03493774⟩
• 
  Arnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, Pierre Blanchard, Dana Hartl, et al.. Anaplastic Thyroid Carcinoma: An Update. Cancers, 2022, 14, ⟨10.3390/cancers14041061⟩. ⟨hal-03859894⟩
• 
  T. Aparicio, A. Darut-Jouve, F. Khemissa Akouz, C. Montérymard, P. Artru, et al.. Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD. Journal of geriatric oncology, 2020, ⟨10.1016/j.jgo.2020.04.001⟩. ⟨hal-02901884⟩
• 
  Akila Saim, François Gernier, Idlir Licaj, Julien Rod, Michel Velten, et al.. Situation professionnelle à long terme après un cancer : étude réalisée à partir de registres de population. Bulletin du Cancer, 2020, 107, pp.867 - 880. ⟨10.1016/j.bulcan.2020.06.004⟩. ⟨hal-03491460⟩
• 
  Paul-Michel Mertes, Olivier Collange, Pierre Coliat, Mainak Banerjee, Marie-Charlotte Diringer, et al.. Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation. Journal of Controlled Release, 2021, 336, pp.252-261. ⟨10.1016/j.jconrel.2021.06.033⟩. ⟨hal-03767483⟩

87

121